CervoMed (CRVO) Deferred Taxes (2014 - 2021)
CervoMed (CRVO) posted Deferred Taxes of -$443893.0 for Q3 2021, up 44.9% sequentially from -$805676.0 in Q3 2020, and up 44.9% YoY from -$306335.3 in Q3 2020.
CervoMed (CRVO) Deferred Taxes (2014 - 2021) Analysis & Trends
CervoMed has reported Deferred Taxes for 5 years, with the latest figure at -$443893.0 in Q3 2021.
- Quarterly Deferred Taxes rose 44.9% year-over-year to -$443893.0 in Q3 2021, while the trailing twelve-month figure through Dec 2022 was -$443893.0 (up 64.48% YoY) and the FY2021 annual result came in at -$443893.0, up 73.5% from the prior year.
- Deferred Taxes grew to -$443893.0 in Q3 2021 per CRVO's latest filing, from -$805676.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $818101.0 in Q4 2019 and troughed at -$805676.0 in Q3 2020.
- A 4-year average of -$195574.6 and a median of -$220226.5 in 2018 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2019 and 2020: Deferred Taxes soared 1712.52% in 2019, then plunged 365.85% in 2020.
- Over 4 years, Deferred Taxes stood at $45136.0 in 2018, then jumped by 1712.52% to $818101.0 in 2019, then sank by 198.48% to -$805676.0 in 2020, then jumped by 44.9% to -$443893.0 in 2021.
- According to Business Quant data, Deferred Taxes over the past three periods registered -$443893.0, -$805676.0, and -$507325.0 for Q3 2021, Q3 2020, and Q2 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -443,893.00 |
| Sep 30, 2020 | -805,676.00 |
| Jun 30, 2020 | -507,325.00 |
| Mar 31, 2020 | -362,380.00 |
| Dec 31, 2019 | 818,101.00 |
| Sep 30, 2019 | -225,960.00 |
| Jun 30, 2019 | -108,904.00 |
| Mar 31, 2019 | -150,352.00 |
| Dec 31, 2018 | 45,136.00 |
| Sep 30, 2018 | -214,493.00 |
| Dec 31, 2014 | -2.43 Mn |
| Sep 30, 2014 | -145,999.00 |